Fox Run Management, L.L.C. Haemonetics Corp Transaction History

Fox Run Management, L.L.C.

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 11, 2023	BUY	$80.84 - $89.45 $1.13 Million - $1.25 Million	14,030 New	14,030 $1.19 Million
Q4 2022 Feb 07, 2023	BUY	$73.85 - $86.14 $929,180 - $1.08 Million	12,582 New	12,582 $989,000
Q2 2021 Aug 05, 2021	SELL	$51.81 - $118.56 $97,869 - $223,959	-1,889 Closed	0 $0
Q1 2021 May 17, 2021	BUY	$111.01 - $139.48 $209,697 - $263,477	1,889 New	1,889 $210,000
Q1 2020 May 08, 2020	SELL	$74.34 - $121.82 $478,823 - $784,642	-6,441 Closed	0 $0
Q4 2019 Feb 14, 2020	BUY	$114.37 - $129.46 $736,657 - $833,851	6,441 New	6,441 $740,000
Q3 2018 Oct 05, 2018	SELL	$89.96 - $114.58 $411,387 - $523,974	-4,573 Closed	0 $0
Q2 2018 Jul 17, 2018	BUY	$71.53 - $95.75 $102,359 - $137,018	1,431 Added 45.54%	4,573 $410,000
Q1 2018 Apr 17, 2018	BUY	$60.72 - $74.41 $190,782 - $233,796	3,142 New	3,142 $230,000

334

54M

689K

345K

Ticker HAE
Exchange NYSE
Sector Healthcare
Industry Medical Instruments & Supplies
Shares Outstandng 51,316,500
Market Cap $3.54B
Description
Haemonetics Corporation, a healthcare company, provides medical products and solutions. It operates through three segments: Plasma, Blood Center, and Hospital. The company offers automated plasma collection devices, related disposables, and software, including NexSys PCS and PCS2 plasmapheresis equipment and related disposables and intravenous s...

Get notified when there are updates to the investment portfolio of Fox Run Management, L.L.C., based on Form 13F filings with the SEC.

Stay updated on Fox Run Management, L.L.C. with notifications on news.